Greiner Bio One International AG

Greiner Bio-One International AG is world market leader in the field of biotechnology, diagnostics, pharmaceutical, medicine and In Vitro diagnostics. The product range is comprehensive, including products for blood collection, urine collection and specimen collection. Our specimen collection systems, blood collection systems and urine collection systems are sold in over 100 countries world wide. The products for blood collection and specimen collection are reliable and simple to use. The VACUETTE® blood collection system consists of blood collection tubes, multiple use drawing needles and various other blood collection accessories. The blood collection system is ideally suited for venous blood collection. The MiniCollect® capillary blood collection system is perfect for capillary blood collection.

           

Capillary Blood Collection System
Preanalytics The Preanalytics business division develops and sells specimen collection systems for hospitals, laboratories and blood banks.
Preanalytics Homepage
BioScience The BioScience business division is a worldwide leading technolgy partner for universities, research institutes as well as the diagnostic and pharmaceutical industries and biotechnology sector.
BioScience Homepage
Mediscan The Mediscan business division is specialised in the sterilisation of food packaging and laboratory components.
Mediscan Homepage

Visit us in our country
17.10.2011 Greiner Bio-One honored as a Leading Enterprise Businesses that see innovation not just as a buzzword, but live out their innovative philosophy in everyday business practices, were honored as leading enterprises at the Welcome Day in Linz on October 4th.
02.11.2011 Share acquisition for Greiner Bio-One in China Greiner Bio-One has acquired the majority share in its Chinese trading partner in Beijing. “A new middle class is developing as a result of urbanization in China and the best in medical care is an ever more important concern of these people. That is why this market with its annual growth of around 20 percent is of special interest to us”, Axel Kühner, Chairman of Greiner Holding AG and Greiner Bio-One International AG said.